By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Whats next Glucagon-like peptide 1 (GLP-1) agonists, used to treat Type 2 diabetes and obesity, have been a success story in the industry, with Novo Nordisk riding a blockbuster wave with Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity, and Eli Lilly and Company also riding the wave with Mounjaro/Zepbound (tirzepatide), a dual-activating GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 medication, respectively for treating Type 2 diabetes and obesity
Made in a plant that manufactures milk, egg, gluten,soy, crustaceans, sulphur dioxide and nuts containing foods
Read on Reddit Starting to like Trimi Health Newer patient discussing initial positive experience and what convinced them to switch to Trimi
But thats just the list price
Kutina, A